Purinethol, Purixan, Mercaptopurine Nova Laboratories, Xaluprine (mercaptopurine) is a small molecule pharmaceutical. Mercaptopurine was first approved as Purinethol on 1982-01-01. It is used to treat b-cell chronic lymphocytic leukemia, non-hodgkin lymphoma, and precursor cell lymphoblastic leukemia-lymphoma in the USA. It has been approved in Europe to treat lymphoid leukemia.
|Trade Name||Mercaptopurine Nova Laboratories, Xaluprine|
|Indication||b-cell chronic lymphocytic leukemia, lymphoid leukemia, non-hodgkin lymphoma, precursor cell lymphoblastic leukemia-lymphoma|
|Drug Class||Aptamers, classical and mirror|